Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
17.36
-0.62 (-3.45%)
At close: Oct 13, 2026, 4:00 PM EDT
17.37
+0.01 (0.06%)
After-hours: Oct 13, 2026, 7:30 PM EDT

Relay Therapeutics Revenue

Relay Therapeutics had revenue of $350.00K in the quarter ending June 30, 2026, a decrease of -48.30%. This brings the company's revenue in the last twelve months to $10.35M, up 23.86% year-over-year. In the year 2025, Relay Therapeutics had annual revenue of $15.36M with 53.44% growth. That makes Relay Therapeutics the 37,174th largest company in the world by revenue and 4,883rd in the United States.

Revenue (ttm)
$10.35M
Revenue Growth
+23.86%
P/S Ratio
367.57
Revenue / Employee
$51,238
Employees
202
Market Cap
3.80B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202515.36M5.35M53.44%
Dec 31, 202410.01M-15.54M-60.83%
Dec 31, 202325.55M24.17M1,749.82%
Dec 31, 20221.38M-1.65M-54.41%
Dec 31, 20213.03M-79.63M-96.34%
Dec 31, 202082.65M--
Dec 31, 2019---
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.